Bischoff Stephan C
Department of Medicine, Nutritional Medicine and Prevention, (140b), University of Hohenheim, Stuttgart, Fruwirthstr 12, 70593 Stuttgart, Germany.
Curr Gastroenterol Rep. 2006 Oct;8(5):374-82. doi: 10.1007/s11894-006-0022-8.
Food incompatibilities affect approximately 20% of the general population in Western countries. In about one quarter of the affected children and one tenth of affected adults, the incompatibility is based on an allergy, that is, on an immunologically generated incompatibility reaction. Gastrointestinal symptoms occur in a third of these cases. Food allergies are caused by IgE-dependent orIgE-independent immunologic reactions, which lead to an inflammatory reaction, in which mast cells, eosinophilic granulocytes, and other cells are involved. Both genetic and environmental causes are under consideration. New findings concerning the interaction between the innate immune system and intestinal microflora have generated innovative therapeutic concepts, including the use of probiotics to prevent food allergies. The development of recombinant allergens and varieties of allergens will improve diagnostic possibilities and bring new therapeutic options, such as hyposensitization and induction of immunologic tolerance. Food intolerances (non-immunologic food incompatibilities often caused by specific enzyme deficiencies) must be diagnostically differentiated from food allergies.
在西方国家,食物不耐受影响着约20%的普通人群。在约四分之一的受影响儿童和十分之一的受影响成年人中,不耐受是基于过敏,即基于免疫产生的不耐受反应。这些病例中有三分之一会出现胃肠道症状。食物过敏由IgE依赖或IgE非依赖的免疫反应引起,这些反应会导致炎症反应,其中肥大细胞、嗜酸性粒细胞和其他细胞会参与其中。遗传和环境因素都在考虑范围内。关于先天免疫系统与肠道微生物群相互作用的新发现产生了创新的治疗理念,包括使用益生菌预防食物过敏。重组过敏原和各种过敏原的开发将改善诊断可能性,并带来新的治疗选择,如减敏和诱导免疫耐受。食物不耐受(通常由特定酶缺乏引起的非免疫性食物不耐受)必须在诊断上与食物过敏区分开来。